G
GRI
GRI Bio
2.200
+0.030+1.38%Pre Market: 2.140 -0.060 -2.73%05:01 06/10 EDT
OPEN/PREV CLOSE2.300/2.170
TODAY RANGE2.114-2.300
VOL7.43K
MARKET CAP3.90M
52 WEEK RANGE1.970-80.36
AVG VOL (3M)82.74K
% TURNOVER4.16%
TURNOVER0
P/E (TTM)-0.0252
% RANGE8.57%
EPS(TTM)-87.4667
P/E(FORWARD)-0.4612
P/B0.3307
BVPS6.65
DIVIDEND--
P/S476.19
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP3.16M
SHARES OUTSTANDING1.77M
NEXT EARNINGS08/12-08/17
FREE FLOAT1.44M
LOT SIZE1
EX-DATE01/26/2026
News
Press Releases
Financial Reports
Profile
TipRanks·6d ago
GRI Bio (GRI) Gets a Buy from Ascendiant
Benzinga·06/01 12:43
Dell Technologies To Gain Nearly 79%? Here Are 10 Analyst Calls Investors Should Know
Dow Jones·06/01 10:38
GRI Bio Price Target Cut to $32.00/Share From $40.00 by Ascendiant Capital
Dow Jones·06/01 10:38
GRI Bio Is Maintained at Buy by Ascendiant Capital
Benzinga·06/01 10:28
Ascendiant Capital Maintains Buy on GRI Bio, Lowers Price Target to $32
Seeking Alpha·05/14 18:31
GRI Bio reports Q1 results
TipRanks·05/14 13:02
GRI Bio Highlights Promising Phase 2a IPF Data, Outlook
Benzinga·05/14 12:45
GRI Bio Q1 EPS $(1.61) Misses $(0.91) Estimate
Reuters·05/14 12:42
GRI Bio Q1 net loss narrows on lower R&D expenses
Reuters·05/14 12:35
GRI BIO Q1 NET INCOME USD -2 MILLION
TipRanks·05/14 10:40
Analysts’ Top Healthcare Picks: GRI Bio (GRI), Ovid Therapeutics (OVID)
TipRanks·04/08 13:21
GRI Bio receives UAE patent allowance for inflammatory disease treatments
Same Industry
Name/Symbol
Change%
Price